ScandiBio Therapeutics
PrivateLast Round
Early Funding
Nov 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ScandiBio Therapeutics is a biotechnology company that develops AI-driven pharmaceutical drugs targeting mitochondrial dysfunction for the treatment of metabolic and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ScandiBio Therapeutics Comparables
Compare ScandiBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vandria | 82% | |
| OrsoBio | 66% | |
| Think Bioscience | 63% |
ScandiBio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 1, 2025 | ||||
| Seed | Jan 1, 2018 |
ScandiBio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 243% MoM, reaching 1.9K.
- May 19, 2026
Monthly visitors increased 196% MoM.
ScandiBio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ScandiBio Therapeutics's valuation, stock price, and market status.
Is ScandiBio Therapeutics a public or private company?
ScandiBio Therapeutics is a private company.
What is the current stock price of ScandiBio Therapeutics?
ScandiBio Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ScandiBio Therapeutics worth (valuation)?
Valuation information for ScandiBio Therapeutics is not publicly available.
Can I buy ScandiBio Therapeutics stock?
ScandiBio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ScandiBio Therapeutics's last funding round?
ScandiBio Therapeutics's most recent funding round was Early Funding on November 1, 2025.
Who are the main investors in ScandiBio Therapeutics?
Key investors in ScandiBio Therapeutics include Navigare Ventures.
Will ScandiBio Therapeutics IPO soon?
No public IPO plans have been announced for ScandiBio Therapeutics.
How can I track ScandiBio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ScandiBio Therapeutics's secondary market activity and sign up for updates.